YES Securities' research report on Aarti Industries
ARTO’s 2QFY23 Adj. Ebitda at Rs 2.7bn (+31.5% YoY; ‐5.2%), stood largely in‐line with our estimates. The YoY growth stemmed from adjustment for shortfall fee of Rs 520mn in base quarter. Higher raw material volatility, lower volume due to maintainance shutdown at Jhagadia and muted demand for discretionary products (dyes & pigments) coupled with QoQ higher operating expense led to sequential drop in operating profits. Going ahead, while Ebitda for 2HFY23 could remain flat (vs 1H), a stronger 25% CAGR is expected over FY24‐25e driven by a) expansion in NCB and Ethylation capacities, b) ramp‐up in LT‐2 (revenue potential : Rs 5.5bn) c) commissioning and ramp‐up of LT‐3 (revenue potential: Rs 940mn) and d) launch of 50+ molecules currently under R&D. Maintain BUY.
Outlook
We maintain BUY rating on ARTO with a revised TP of Rs 845/sh, as we align our estimates to re‐stated, post demerger financials and roll estimates forward to FY25e. Our TP is premised upon an operating earnings growth CAGR of 10% (FY22‐30e) and RoEs of ~15‐16%.
For all recommendations report, click here
Disclaimer: The views and investment tips expressed by investment experts/broking houses/rating agencies on moneycontrol.com are their own, and not that of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
Find the best of Al News in one place, specially curated for you every weekend.
Stay on top of the latest tech trends and biggest startup news.